This second event organized by ReproYoung on 22 May once again filled the auditorium with an incredibly engaged audience at Medicon Valley Alliance in Copenhagen. The topic was male and female infertility – assessment and prognostic factors – featuring two insightful talks by leading voices in the field.
Anja Pinborg from The Fertility Department at Rigshospitalet talked about “Female Infertility: So Much Yet to Be Understood”, highlighting:
- Each year there are 40,000 fertility treatments in Denmark, including 25,000 cycles with in-vitro fertilisation (IVF) – 10% of a birth cohort is born after fertility treatment.
- Oocyte quality and the ovarian reserve significantly impact fertility, with references to recent work by amongst other Stine Gry Kristensen, Eva Hoffmann and Jennifer Gruhn.
- We’re now ready to harvest the fruits of the samples and data collected from 2000 couples as part of the ReproUnion Biobank & Infertility Biobank – RUBIC is fueling research projects on cardiometabolic risk markers, the microbiome, genetics and more.
Niels Jørgensen from the Dept of Growth and Reproduction explained how “Infertile Men Also Need to Be Taken Care Of”, highlighting:
- That fetal life is vital to testicular function!
- The reproductive hormones and capacity of the future semen quality are shaped already in the first months of the mother’s pregnancy.
- Recent publications point to semen quality as a biomarker for future health.
The event ended with an energetic panel session, packed with insightful questions and answers by Anja and Niels. Well done to the ReproYoung team for pulling off this second successful event!
The appetite for more ReproTalks is clearly growing and it was announced that the next ReproTalk will take place on 8 September, featuring Kirsten Tryde Macklon and Stine Gry Kristensen on the topic: Protecting future female fertility – fertility preservation prior to gonodotoxic treatment.
